News Sentiment

VBIO sentiment intelligence

Valion Bio Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 30 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.51 Week of 17 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

84/100 classification confidence.

Company focus 21

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-0.8% over one week, -2.8% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

World-Premier Cancer Center Sheba Medical Center Selects Entolimod for Clinical Trial, Potentially Expanding Valion Bio into the Multi-Billion-Dollar Neutropenia Market

Market Reaction

Balanced read

49/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 84/100 classification
One-week reaction -0.8% Price digesting
Trend fit Trend inactive -2.8% over four weeks
Fair value -95.6% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 27
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 21
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 8
PR Newswire 7
Market source 7
simplywall.st 2
Investing.com Nigeria 1
Investing.com Canada 1
marketscreener.com 1
The Globe and Mail 1

Event Lens

What the news is about

Classified themes
Market update 19
Earnings 11

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 30